Stay updated on Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page
- Check7 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1. The study record content is unchanged.SummaryDifference0.1%

- Check14 days agoChange DetectedThe ClinicalTrials.gov site's displayed revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe record history shows a new Revision: v3.7.0 replacing the previous v3.6.6, indicating a page version update rather than changes to the study details.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry v3.6.6 was added to the record history, and the previous revision v3.6.5 was removed from the history.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry (v3.6.5) was added to the study record history, and the previous revision (v3.6.4) was removed from the current listing, indicating a platform version update rather than content changes.SummaryDifference0.1%

- Check91 days agoChange DetectedA new site release version, v3.6.4, is added to the record history, replacing the previous release v3.6.3.SummaryDifference0.1%

Stay in the know with updates to Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page.